Let's Talk Particulates: Working Towards Best Practices
Saturday, June 1, 2024 09:00 AM - 10:00 AM
Room 205-207
Bioprocessing & Manufacturing
Roundtable
Moderator
Leverage key takeaways from ISCT's survey of developers and biomanufacturers to establish effective particulate management strategies.
Key Learning Objectives
1. Share key trends observed in the survey of how, when, and where to find particulate in the manufacturing process
2. Increase awareness of key guidance documents for North America and Europe
3. Discuss the concept of a particulate budget and how this applies to suppliers and therapy developers
- Samuel Molina, PhD, American Red Cross, United States
- Elaine Peters, PhD, Genentech, United States
- Beate Wagner, MD, University Hospital Innsbruck, Austria
- Paul Dyer, MSc, PhD, Halo Labs, United States
- Mark Broadley, MBA, BioCentriq, United States
Leverage key takeaways from ISCT's survey of developers and biomanufacturers to establish effective particulate management strategies.
Key Learning Objectives
1. Share key trends observed in the survey of how, when, and where to find particulate in the manufacturing process
2. Increase awareness of key guidance documents for North America and Europe
3. Discuss the concept of a particulate budget and how this applies to suppliers and therapy developers
